Helixate

Essentials Factor VIII inhibitors are the most serious complication in patients with hemophilia A. Aggregates in… (More)

Although it has been suggested that switching of factor VIII (FVIII) products may increase inhibitor formation this is disputed… (More)

The administration of therapeutic factor VIII (FVIII) to treat or prevent haemorrhages in haemophilia A patients results, in up… (More)

patient decide. Inhibitor formation is a multicausal process and FVIII exposure is undeniably a necessary cause of inhibitors… (More)

Sucrose-formulated octocog alfa (Kogenate Bayer, Kogenate FS, Helixate FS, Helixate nexgen) is a full-length recombinant human… (More)

The state-of-the-art treatment for hemophilia A is replacement therapy with recombinant factor VIII (rFVIII) made possible by… (More)

Recombinant hirudin (rH) is a highly specific thrombin inhibitor which is under clinical investigation for various thrombotic… (More)